NovaBridge Biosciences (NBP) stock
NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.90+0.08 (+9.83%)
Close on Nov 18, 2026Market cap $104.20MP/E –Yield –
NovaBridge Biosciences net income
Net income is the profit left for shareholders after every expense, interest and tax.
NovaBridge Biosciences's net income for the twelve months ending Dec 31, 2020 was CN¥470.92M. For fiscal 2023 it was -CN¥1.47B. The highest annual figure on record is CN¥470.92M in fiscal 2020.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -CN¥1.47B | – |
| FY2022 | Dec 31, 2022 | -CN¥2.51B | – |
| FY2021 | Dec 31, 2021 | -CN¥2.33B | -595.1% |
| FY2020 | Dec 31, 2020 | CN¥470.92M | – |
| FY2019 | Dec 31, 2019 | -CN¥1.45B | – |
| FY2018 | Dec 31, 2018 | -CN¥402.83M | – |
| FY2017 | Dec 31, 2017 | -CN¥298.24M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2020 | Dec 31, 2020 | CN¥1.04B | – |
| Q4 FY2019 | Dec 31, 2019 | -CN¥348.57M | – |
See a number that looks wrong?